WuXi AppTec (OTCMKTS:WUXAY) Announces Quarterly Earnings Results

WuXi AppTec (OTCMKTS:WUXAY) issued its quarterly earnings data on Monday. The company reported $0.23 EPS for the quarter, beating the consensus estimate of $0.18 by $0.05, Zacks reports.

WuXi AppTec Stock Performance

Shares of OTCMKTS WUXAY opened at $15.50 on Monday. The stock’s 50-day moving average is $15.02 and its two-hundred day moving average is $14.21. WuXi AppTec has a 1-year low of $7.09 and a 1-year high of $17.00.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on the company. Zacks Research upgraded WuXi AppTec to a “hold” rating in a research report on Monday, April 13th. The Goldman Sachs Group upgraded WuXi AppTec to a “buy” rating in a research report on Thursday, February 5th. One research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy”.

About WuXi AppTec

WuXi AppTec is a global contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. Headquartered in Shanghai and founded in 2000, the company provides end-to-end solutions that span drug discovery, development and manufacturing. Its offerings enable customers to accelerate the research and development process for small molecules, biologics, cell and gene therapies, as well as medical devices.

Key services include chemistry and biology discovery support, preclinical safety assessment, analytical and formulation development, clinical manufacturing, large-scale biomanufacturing, and quality testing.